With a San Francisco biotech company, an UdeM eye expert develops a treatment that could potentially treat patients who suffer from this degenerative disease of the retina.

Eighty-five per cent of staffers in hospitals and long-term-care centres coped well with the mental stress they experienced during and after the first wave of the COVID-19 pandemic last year.

Taking cannabidiol, a chemical in the cannabis sativa plant, appears ineffective in treating cocaine use disorder, researchers at the CHUM Research Centre find.

A research team led by UdeM psychology and neuroscience professor Sylvie Belleville has just targeted an early biomarker of the disease.

A CHU Sainte-Justine study of clinical characteristics and disease severity in infants with COVID-19 shows that those who've contracted the SARS-CoV-2 virus have done surprisingly well.

Researchers at three Canadian universities find the key to unlocking the antidepressant effect of ketamine in the brain.

Three types of medications approved for other clinical purposes may reduce the inflammatory symptoms caused by the SARS-CoV-2 virus, an UdeM-led study finds.

An ongoing, UdeM-led study of youths on the West Island and in the Plateau Mont-Royal finds few have had the virus, but their mental health is an issue.

UdeM neurobiologist Janelle Drouin-Ouellet is reprogramming neuronal cells from skin samples of elderly Parkinson’s patients to see how the cells change over time – and discover new treatments.

Ravi Rungta, a young assistant professor of dentistry at UdeM, is recognized by the Brain Canada Foundation as one of the country's top 20 leaders in brain research.